288 related articles for article (PubMed ID: 17868650)
1. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions.
Taraboletti G; Benelli R; Borsotti P; Rusnati M; Presta M; Giavazzi R; Ruco L; Albini A
J Pathol; 1999 May; 188(1):76-81. PubMed ID: 10398144
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
[TBL] [Abstract][Full Text] [Related]
4. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein.
Hui B; Xia W; Li J; Wang L; Ai J; Geng M
J Neurochem; 2006 Apr; 97(2):334-44. PubMed ID: 16539678
[TBL] [Abstract][Full Text] [Related]
5. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
6. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128
[TBL] [Abstract][Full Text] [Related]
8. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, decreased vulnerability of PC12 cells to human immunodeficiency virus tat protein through attenuating calcium overload.
Hui B; Li J; Geng MY
J Neurosci Res; 2008 Apr; 86(5):1169-77. PubMed ID: 18092356
[TBL] [Abstract][Full Text] [Related]
9. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo RC
J Clin Invest; 1994 Nov; 94(5):1736-46. PubMed ID: 7525646
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
[TBL] [Abstract][Full Text] [Related]
12. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients.
Ensoli B; Barillari G; Salahuddin SZ; Gallo RC; Wong-Staal F
Nature; 1990 May; 345(6270):84-6. PubMed ID: 2184372
[TBL] [Abstract][Full Text] [Related]
13. The expression of CD154 by Kaposi's sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-TAT protein.
Cantaluppi V; Deregibus MC; Biancone L; Deambrosis I; Bussolati B; Albini A; Camussi G
Int J Immunopathol Pharmacol; 2006; 19(1):81-96. PubMed ID: 16569346
[TBL] [Abstract][Full Text] [Related]
14. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
Fiorelli V; Gendelman R; Samaniego F; Markham PD; Ensoli B
J Clin Invest; 1995 Apr; 95(4):1723-34. PubMed ID: 7535796
[TBL] [Abstract][Full Text] [Related]
15. Sulfated polymannuroguluronate inhibits Tat-induced SLK cell adhesion via a novel binding site, a KKR spatial triad.
Wu YL; Ai J; Zhao JM; Xiong B; Xin XJ; Geng MY; Xin XL; Jiang HD
Acta Pharmacol Sin; 2011 May; 32(5):647-54. PubMed ID: 21499289
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B
J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice.
Samaniego F; Markham PD; Gallo RC; Ensoli B
J Immunol; 1995 Apr; 154(7):3582-92. PubMed ID: 7897237
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2.
Albini A; Fontanini G; Masiello L; Tacchetti C; Bigini D; Luzzi P; Noonan DM; Stetler-Stevenson WG
AIDS; 1994 Sep; 8(9):1237-44. PubMed ID: 7528513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]